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Thanks to diagnostic and therapeutic advances, the elderly population is continuously
increasing in the western countries. Accordingly, the prevalence of most chronic
age-related diseases will increase considerably in the next decades, thus it will be
necessary to implement effective preventive measures to face this epidemiological
challenge. Among those, physical activity exerts a crucial role, since it has been
proven to reduce the risk of cardiovascular diseases, diabetes, obesity, cognitive
impairment and cancer. The favorable effects of exercise on cardiovascular homeostasis
can be at least in part ascribed to the modulation of the neuro-hormonal systems
implicated in cardiovascular pathophysiology. In the elderly, exercise has been shown
to affect catecholamine secretion and biosynthesis, to positively modulate the
renin-angiotensin-aldosterone system and to reduce the levels of plasma brain natriuretic
peptides. Moreover, drugs modulating the neuro-hormonal systems may favorably affect
physical capacity in the elderly. Thus, efforts should be made to actually make physical
activity become part of the therapeutic tools in the elderly.
Keywords: physical activity, elderly, sympathetic nervous system, renin-angiotensin-aldosterone system, brain
natriuretic peptide
INTRODUCTION
Aging is a physiological process influenced by both genetic
and environmental factors and the mechanisms involved mainly
remains unknown. In the US, more than 3 million citizens are
presently 85 years or older and the elderly population is prob-
ably expected to further rise by 2040. This escalation is due to
increase in average age (thanks to improvements in diagnostic and
therapeutic tools). Furthermore, the prevalence of most chronic
age-related diseases will begin to increase considerably within the
next two decades (Vogel et al., 2009). Consequently, it will be
necessary to implement effective preventive measures against the
progression of chronic diseases, focusing above all on life style
measures.While no intervention has been shown to increase over-
all longevity, some seems to influence the aging process. Among
these, physical activity exerts a crucial role, in addition to healthy
balanced diet and psychosocial wellbeing (Gremeaux et al., 2012).
It is known that physical exercise beneficially affects the human
body in a multifactorial way. Indeed, with the exclusion of diet
modification, no other single intervention has a greater promise
than physical exercise to reduce the risk of the most common
chronic diseases at the same time. Regular physical activity has
clearly been shown to reduce the risk of cardiovascular disease,
stroke, hypertension, type 2 diabetes, obesity, osteoporosis, cancer
(e.g., colon and breast cancer) and psychiatric pathologies as anx-
iety and depression. There is some evidence that exercise training
also prevents or delays cognitive impairment and improves qual-
ity sleep, combating insomnia. Clinical guidelines also identify a
role for exercise in the comprehensive management of demen-
tia, chronic pain, congestive heart failure, stroke, prophylaxis of
venous thromboembolism (Booth et al., 2000, 2011; Marciano
et al., 2012; Paolillo et al., 2013).
Moreover, it is widely recognized that exercise also has impor-
tant effects on diverse neuro-hormonal systems that can be altered
in the elderly especially during the course of most common geri-
atric diseases. In this mini-review, we will explore how some of
the most important systems regulating cardiovascular homeosta-
sis can be affected by aging and how physical activity can have a
crucial role in preventing this deterioration.
SYMPATHETIC NERVOUS SYSTEM IN THE ELDERLY AND ITS
MODULATION BY EXERCISE TRAINING
The sympathetic nervous system (SNS) is a pivotal modulator
of some important functions and particularly of cardiovascular
and metabolic ones. Through the SNS, the central nervous sys-
tem maintains the homeostasis after acute and chronic stimuli, as
well as in response to the development of pathological conditions
(Davy et al., 1995; Esler et al., 1995; Zincarelli et al., 2010). Many
studies evaluated the effects of aging on SNS under basal con-
ditions and in response to acute physical and mental-emotional
stress. It has been established that SNS activity, as estimated from
total plasma norepinephrine spillover, is greater in older healthy
adults compared to young controls. This sympathetic overdrive
in advanced age is related to the elevation in basal tonic activity
rather than in response to stress and is mainly due to SNS outflow
in peripheral tissues (Seals and Esler, 2000).
Some authors have hypothesized that one of the key mecha-
nisms underlying this increase in tonic SNS activity in elderly is
the increasing in total and abdominal adiposity and in circulating
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adipose-sensitive signals (e.g., leptin) and augmented brain nora-
drenergic activity (Femminella et al., 2013), as evaluated by mea-
surements of norepinephrine spillover from the cerebrovascular
circulation. It has been speculated that increasing in tonic SNS
activity with aging could be an adaptive response to increasing
accumulation of visceral body fat (Seals and Dinenno, 2004).
SNS over-activation has detrimental effects on the cardiovas-
cular system mainly during clinical diseases such as congestive
heart failure and essential hypertension. It has been demonstrated
that the raise in SNS activity with aging contributes to increasing
in arterial blood pressure observed in older adults. In addition,
aging is related with impaired limb vasoconstrictor responsive-
ness to chronic SNS stimulation via α1-adrenergic receptors
pathway (Dinenno et al., 1999). In particular, SNS overactiv-
ity and augmented local and systemic release of norepinephrine
may stimulate the production of reactive oxygen species in the
vascular wall by a α1-adrenergic-dependent mechanism, con-
tributing to arterial wall hypertrophy. Moreover, increasing in
SNS activity in the elderly also appears to have important effects
on β-Adrenergic Receptor (β-AR) leading to some consequences
on cardiovascular system. Particularly, chronic β-AR stimula-
tion in aging affects vasodilatation, heart rate regulation and left
ventricular contractility as demonstrated in both experimental
animals and humans (Ferrara et al., 1997; Rengo et al., 2012c,
2013a). The mechanisms implicated in β-AR reduced respon-
siveness with aging seem involve both receptor and postreceptor
elements of the β-adrenergic signaling. It has been suggested that
the tonic raise in SNS activity with aging causes agonist-induced
downregulation of β-ARs, desensitization of the β-ARs signaling
pathway, and reduced vascular and cardiac tissue responsiveness
to acute and chronic β-AR stimuli (Rengo et al., 2009b, 2012b,d;
Lymperopoulos et al., 2012; Cannavo et al., 2013a; Salazar et al.,
2013).
Regular physical activity reduces the risk of cardiovascular dis-
eases, increases cardiovascular function in healthy subjects and
in particular in patients with cardiovascular disease, is benefi-
cial in controlling hypertension, can increase longevity in animal
models and also quality of life in humans (Conti et al., 2012,
2013). Exercise exerts effect on cardiovascular risk factors mainly
through reduction of platelet aggregation, increase in blood flow
and oxygen delivery to skeletal muscle, improvement of cardio-
respiratory fitness, reduction of body weight, improvement of
lipid profile and increase in insulin sensitivity (Rinaldi et al., 2006;
Rengo et al., 2010a, 2012a, 2013b,d; Barcelos-Ferreira et al., 2013).
Training-induced decreases in sympathetic activity may be
beneficial in preventing arterial stiffening in hypertension; it has
been recently demonstrated that in elderly hypertensives 12 weeks
of training resulted in comparable reductions in blood pressure
and improvements of endothelial function both in the presence
and absence of beta-blockade, suggesting that drug therapy pro-
vided no additive benefit and did not affect the antihypertensive
activity of exercise training (Fu et al., 2008).
However, the effects of exercise training on circulating cat-
echolamines in elderly humans are controversial. In some
studies, regular exercise does not seem to influence plasma
norepinephrine levels in elderly subjects with normal plas-
matic catecholamines, whereas exercise training decrease plasma
norepinephrine concentrations in elderly humans with elevated
baseline levels. In addition, exercise training reduces both systolic
and diastolic blood pressure in young and elderly hypertensive
subjects (Kohrt et al., 1993).
Physical activity could act in diminishing circulating cate-
cholamines by a decrease in catecholamine biosynthesis. Tumer
et al. demonstrated that long-term (10 weeks) treadmill exer-
cise determinates adaptive changes in young rats that lead to a
decrease in tyrosine hydroxylase expression and activity in the
adrenal medulla, but the same training schedule failed to decrease
the previously elevated tyrosine hydroxylase level and activity in
the old rats (Tumer et al., 2001).
However, some authors hypothesize that forced modes of exer-
cise, like treadmill training, may induce by themselves a stress
response, and these stressor effects of forced exercise might be
more evident in senescent animals, abolishing the beneficial
effects of exercise training (Moraska et al., 2000). More recently,
Erdos et al. have showed that age-related changes in the levels of
catecholamine biosynthetic enzymes in the adrenal medulla and
hypothalamus can be abolished with only 8% restriction in daily
caloric intake, while life-long voluntary exercise does not have
any additional effect over caloric restriction (Erdos et al., 2007;
Lymperopoulos et al., 2008, 2009, 2011).
Our group has shown that in a chronic diseases character-
ized by SNS hyperactivity, such as heart failure, exercise train-
ing (Rengo et al., 2007, 2010a; Lymperopoulos et al., 2010;
Cannavo et al., 2013b) has beneficial effects on curbing the
cardiotoxic effects of sympathetic overactivation, exerting a sim-
ilar (and/or complementary) neurohormonal action to that
of β-blockers in combating the autonomic derangements that
confound and aggravate chronic heart failure (Rengo et al.,
2004, 2009a; Lymperopoulos et al., 2013). Thus, it could be
hypothesized that regular physical activity can have benefi-
cial effects also in the aging process through the modulation
of the sympathetic tone (Leosco et al., 2007; Rengo et al.,
2010b).
RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN THE
ELDERLY AND ITS MODULATION BY EXERCISE
The renin-angiotensin-aldosterone system (RAAS) regulates car-
diovascular functions under both normal and pathologic condi-
tions, through receptors widely distributed in the whole body.
RAAS increased activity is associated with the establishment
and development of hypertension, cardiovascular events, and
chronic kidney disease and drugs modulating this system are very
important and diffused tools for the treatment of essential hyper-
tension and other cardiac and vascular diseases. In the RAAS
cascade angiotensinogen is cleaved by renin to form angiotensin
I (AngI), which, in turn, is converted to angiotensin II (AngII) by
angiotensin-converting enzyme (ACE) (Fyhrquist and Saijonmaa,
2008). AngII has direct action on renal tubular sodium retention
and stimulate the secretion of aldosterone in the adrenal glands,
which in turn determinates salt and water reuptake by the kid-
neys. Thus, the RAAS is a key system in blood pressure regulation
through the modulation of body fluids and electrolyte concentra-
tions. Moreover, the importance of AngII was mostly clear when
some authors showed that deletions of the AT1A receptors or ACE
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genes significantly decrease systolic blood pressure in mice (Cole
et al., 2000).
It has been shown in recent times that pharmacological
inhibitors of the RAAS are also able to increase levels of the
heptapeptide angiotensin-(1–7). This peptide is formed by cleav-
age of either AngI by various endopeptidases or from AngII by
ACE and its actions counteracts the deleterious cardiovascular
effects of AngII, as angiotensin-(1–7) induces vasodilation and
facilitation of baroreflex sensitivity. These findings are particu-
larly interesting because an imbalance in AngII and angiotensin-
(1–7) levels is involved in aging and in several animal models of
hypertension, a typical disease of the elderly (Iyer et al., 1998).
In addition to that, chronic therapies with ACE inhibitors
or AT1 receptor blockers (ARBs) improves or prevents deficits
in cardiovascular, metabolic and renal function during aging
in normotensive and hypertensive rodents. A recent study has
demonstrated that global disruption of the AT1A receptor in mice
augmented survival through attenuation of age-related mito-
chondrial dysfunction and oxidative stress as well as upregulation
of antiapoptotic genes (Benigni et al., 2009; Corbi et al., 2012).
During aging, AT1A receptor knockout mice also exhibit a
lean phenotype and preserved bonemass and cerebral endothelial
function (Arnold et al., 2013). These findings indicate that both
ACE and the AT1 receptor might have detrimental consequences
in age-related pathologies; however, the mechanisms involved in
the beneficial effects of RAAS blockade or genetic deletion dur-
ing aging remain unclear. Particularly, it is not completely clear
whether these effects are peripheral or central: chronic thera-
pies involving RAAS or global deletion of RAAS receptors and
enzymes might not only influence brain regions involved in car-
diovascular and metabolic control, but also block local AngII
effects on peripheral tissues. Moreover, ACE inhibitors and ARBs
change the balance of the RAAS augmenting angiotensin-(1–7)
levels, and this may be important during aging (and conse-
quently for old patients with heart disease and hypertension),
when deficiency of this peptide also contributes to impairments
in baroreflex sensitivity (Iyer et al., 1998).
Some authors have also shown that plasma renin activity
and renin responsiveness decrease with age, possibly due to the
effect of age-associated nephrosclerosis. Plasma aldosterone is
also decreased during aging, leading to an augmented risk for
hyperkalemia in older individuals, especially in old patients with
decline in glomerular filtration rate (Turgut et al., 2010).
Pharmacological therapy with ACE inhibitors could improve
physical function in elderly people. ACE inhibitors amelio-
rate endothelial function and may enhance muscle function by
increasing muscle blood flow and glucose delivery. In particular,
an observational study on elderly women with hypertension con-
firmed that ACE inhibitors slowed the decline in physical function
and muscle strength when compared with other antihyperten-
sive agents and in a randomized placebo-controlled trial, ACE
inhibitors permitted a significant enhancement in exercise capac-
ity among elderly patients with heart failure (Onder et al., 2002;
Henriksen and Jacob, 2003). Although this effect may have been
the result of improved cardiac function, ACE inhibitors may have
direct effects on skeletal muscle. Furthermore, a recent study has
also verified that the ACE inhibitor perindopril enhanced exercise
functional capacity in elderly people without heart failure and
maintained health-related quality of life (Sumukadas et al., 2007).
Some studies have also evaluated the possible correlations
between ACE genotype, exercise training and blood pressure con-
trol. ACE plasma levels may be related to the insertion/deletion
(I/D) polymorphism of the ACE gene, located on chromosome
17. Dengel et al. showed no significant interaction between geno-
type and aerobic training in relation to blood pressure, while
another report showed that 10 weeks of aerobic exercise consid-
erably decreased blood pressure only in patients with genotypes
II and ID, and not in the subjects with the DD genotype of ACE
(Dengel et al., 2002). Blanchard et al. showed a greater diastolic
pressure fall in subjects with DD genotype compared to geno-
types II and ID after mild aerobic training and Kim observed that,
in adult women, the DD genotype showed greater diminution
of diastolic pressure, compared to the II group, when perform-
ing aerobic and resistance exercise (Blanchard et al., 2006; Kim,
2009).
Limited data are available on the effects of exercise training
on hormones plasma levels in healthy elderly. A previous study
by Carroll et al. evaluated the effects of 6 months of endurance
training on plasma hormones in the elderly. They showed that
levels of adrenocorticotropic hormone, vasopressin, aldosterone,
norepinephrine and epinephrine remained unchanged after the
training (Carroll et al., 1995).
Emerging data demonstrate a pivotal role for the RAAS in
modulation of autonomic nervous system pathways participating
in the regulation of cardiovascular and metabolic functions, and
this could be most relevant during aging, especially due to its role
in blood pressure regulation.
BRAIN NATRIURETIC PEPTIDE (BNP) LEVELS IN ELDERLY
PATIENTS AND THE EFFECTS OF EXERCISE TRAINING
BNP is a 32 amino acid peptide and usually it is measured by its
N-terminal fragment (NT-pro-BNP), since the N-terminal part
seems to be more stable than BNP itself. BNP is a cardiac neuro-
hormone secreted from the ventricles in response to volume
expansion and pressure overload (myocyte stress) and has dif-
ferent systemic effects, such as vasodilation, augment in urinary
volume and sodium output, and inhibition of SNS and RAAS sys-
tems. Increasing in plasma levels of BNP and NT-pro-BNP are
generally related to a regional or global impairment of left ven-
tricular (LV) systolic or diastolic function (LV wall stress). It has
been demonstrated that BNP measurement is a reproducible and
sensitive method to monitor LV systolic and diastolic dysfunc-
tion, and both BNP and NT-pro-BNP are strong predictors of
morbidity and mortality in patients with heart failure and coro-
nary heart disease (Hall, 2004; Kragelund et al., 2005). Moreover,
plasma levels of BNP tend to be higher in older patients with or
without cardiac dysfunction and the increase in elderly could be
explained by the loss of clearance receptors with aging or by the
recent evidence that BNP and NT-proBNP correlate with renal
function and decreased glomerular filtration rate can markedly
has a significant prevalence in the elderly population (Krupicka
et al., 2009).
In addition to that, BNP increases with age and has a prog-
nostic value in healthy elderly subjects, in functionally impaired
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patients and in elderly patients with cardiovascular diseases.
Augmented BNP levels have detrimental systemic effects on
skeletal muscle (reduced blood flow, cachexia), myocardium
(adverse LV remodeling, decreased cardiac contractility) and
vasculature (development of atherosclerosis, oxidative stress,
endothelial cell apoptosis and adverse vascular remodeling)
(Wallen et al., 1997; Anker and von Haehling, 2004).
Some authors have showed that physical activity is able to
reduce BNP levels in heart failure patients, and these results
have been also confirmed in recent systematic reviews and meta-
analysis (Smart and Steele, 2010; Smart et al., 2012; Rengo
et al., 2013c; Savarese et al., 2013). Data on elderly heart failure
patients also demonstrate that exercise training is associated with
a decrease of NTpro-BNP plasma levels and with an improve-
ment of cardiovascular function, with ameliorated LV systolic
function and intraventricular pressure (Giallauria et al., 2006).
A recent study has evaluated the relationship between objectively
measured daily walking duration in the elderly and cardiovascu-
lar biomarkers of inflammation, cardiac dysfunction and renal
impairment, including NT-proBNP. In this work physical activ-
ity has shown beneficial effects on cardiovascular risk factors
like blood pressure, blood lipids and inflammation markers,
which were inversely associated with walking (Klenk et al., 2013).
Moreover, objectively measured walking duration showed an
inverse dose-response relationship with the circulating biomark-
ers of cardiac dysfunction.
CONCLUSIONS
Though aging is inescapable, yet its effects can be counteracted.
It is well-established that sedentary lifestyles accelerate aging by
increasing risks of chronic diseases and reducing the average life
expectancy. Exercise can help to ameliorate the quality of life,
mainly preserving functional reserve in the elderly. Numerous
studies have shown thatmaintaining regular andminimal exercise
training decreases the risk of cardiovascular morbidity and mor-
tality and ameliorates themodulation of neuro-hormonal systems
regulating cardiovascular pathophysiology.
Thus, physical inactivity remains a major health challenge
for the elderly and, although the benefits seem to be linked to
the intensity of training, exercise prescription still needs to be
clarified to enable the scientific community to develop precise
recommendations.
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